![Logo of OpenAlex.org Project OpenAlex Citations Logo](https://www.oahelper.org/wp-content/plugins/oahelper-citations/img/logo-openalex.jpg)
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Bacterially mediated drug delivery and therapeutics: Strategies and advancements
Leyang Wu, Feifei Bao, Lin Li, et al.
Advanced Drug Delivery Reviews (2022) Vol. 187, pp. 114363-114363
Closed Access | Times Cited: 42
Leyang Wu, Feifei Bao, Lin Li, et al.
Advanced Drug Delivery Reviews (2022) Vol. 187, pp. 114363-114363
Closed Access | Times Cited: 42
Showing 1-25 of 42 citing articles:
Role of the gut microbiota in anticancer therapy: from molecular mechanisms to clinical applications
Lin-Yong Zhao, Jia-Xin Mei, Gang Yu, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 130
Lin-Yong Zhao, Jia-Xin Mei, Gang Yu, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 130
Modulating gut microbiome in cancer immunotherapy: Harnessing microbes to enhance treatment efficacy
Xing Kang, Harry Cheuk-Hay Lau, Jun Yu
Cell Reports Medicine (2024) Vol. 5, Iss. 4, pp. 101478-101478
Open Access | Times Cited: 29
Xing Kang, Harry Cheuk-Hay Lau, Jun Yu
Cell Reports Medicine (2024) Vol. 5, Iss. 4, pp. 101478-101478
Open Access | Times Cited: 29
Camouflaging attenuated Salmonella by cryo-shocked macrophages for tumor-targeted therapy
Leyang Wu, Zengzheng Du, Lin Li, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 10
Leyang Wu, Zengzheng Du, Lin Li, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 10
Harnessing anti-inflammatory pathways and macrophage nano delivery to treat inflammatory and fibrotic disorders
Ahmad Zaid, Amiram Ariel
Advanced Drug Delivery Reviews (2024) Vol. 207, pp. 115204-115204
Closed Access | Times Cited: 9
Ahmad Zaid, Amiram Ariel
Advanced Drug Delivery Reviews (2024) Vol. 207, pp. 115204-115204
Closed Access | Times Cited: 9
Engineered Microorganisms for Advancing Tumor Therapy
Jinxuan Jia, Xiaocheng Wang, Xiang Lin, et al.
Advanced Materials (2024) Vol. 36, Iss. 24
Closed Access | Times Cited: 6
Jinxuan Jia, Xiaocheng Wang, Xiang Lin, et al.
Advanced Materials (2024) Vol. 36, Iss. 24
Closed Access | Times Cited: 6
Dual‐Engineered Macrophage‐Microbe Encapsulation for Metastasis Immunotherapy
Leyang Wu, Liyuan Qiao, Shu‐Hui Zhang, et al.
Advanced Materials (2024)
Closed Access | Times Cited: 6
Leyang Wu, Liyuan Qiao, Shu‐Hui Zhang, et al.
Advanced Materials (2024)
Closed Access | Times Cited: 6
Bacterial carrier-mediated drug delivery systems: a promising strategy in cancer therapy
Shaomin Yan, Yu Gan, Huizhe Xu, et al.
Frontiers in Bioengineering and Biotechnology (2025) Vol. 12
Open Access
Shaomin Yan, Yu Gan, Huizhe Xu, et al.
Frontiers in Bioengineering and Biotechnology (2025) Vol. 12
Open Access
Anaerobic Probiotics-in situ Se nanoradiosensitizers Selectively Anchor to Tumor with Immuno-regulations for Robust Cancer Radio-immunotherapy
Yangyang Yu, Ying Wang, Jilei Zhang, et al.
Biomaterials (2025) Vol. 318, pp. 123117-123117
Closed Access
Yangyang Yu, Ying Wang, Jilei Zhang, et al.
Biomaterials (2025) Vol. 318, pp. 123117-123117
Closed Access
The role of bacteria and its derived biomaterials in cancer radiotherapy
Yu Zhang, Ruizhe Huang, Yunchun Jiang, et al.
Acta Pharmaceutica Sinica B (2022) Vol. 13, Iss. 10, pp. 4149-4171
Open Access | Times Cited: 29
Yu Zhang, Ruizhe Huang, Yunchun Jiang, et al.
Acta Pharmaceutica Sinica B (2022) Vol. 13, Iss. 10, pp. 4149-4171
Open Access | Times Cited: 29
Single-cell encapsulation systems for probiotic delivery: Armor probiotics
Runan Zhao, Ting Yu, Jiaheng Li, et al.
Advances in Colloid and Interface Science (2024) Vol. 332, pp. 103270-103270
Closed Access | Times Cited: 5
Runan Zhao, Ting Yu, Jiaheng Li, et al.
Advances in Colloid and Interface Science (2024) Vol. 332, pp. 103270-103270
Closed Access | Times Cited: 5
Bacterial derivatives mediated drug delivery in cancer therapy: a new generation strategy
Muhammad Ijaz, Ikram Hasan, Tamoor Hamid Chaudhry, et al.
Journal of Nanobiotechnology (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 5
Muhammad Ijaz, Ikram Hasan, Tamoor Hamid Chaudhry, et al.
Journal of Nanobiotechnology (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 5
Cytosolic delivery of monobodies using the bacterial type III secretion system inhibits oncogenic BCR: ABL1 signaling
Chiara Lebon, Sebastian Großmann, Greg Mann, et al.
Cell Communication and Signaling (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 4
Chiara Lebon, Sebastian Großmann, Greg Mann, et al.
Cell Communication and Signaling (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 4
MOTS-c: A promising mitochondrial-derived peptide for therapeutic exploitation
Yuejun Zheng, Zilin Wei, Tianhui Wang
Frontiers in Endocrinology (2023) Vol. 14
Open Access | Times Cited: 12
Yuejun Zheng, Zilin Wei, Tianhui Wang
Frontiers in Endocrinology (2023) Vol. 14
Open Access | Times Cited: 12
Tumor-targeting engineered probiotic Escherichia coli Nissle 1917 inhibits colorectal tumorigenesis and modulates gut microbiota homeostasis in mice
Haibo Tang, Tuoyu Zhou, Weilin Jin, et al.
Life Sciences (2023) Vol. 324, pp. 121709-121709
Closed Access | Times Cited: 12
Haibo Tang, Tuoyu Zhou, Weilin Jin, et al.
Life Sciences (2023) Vol. 324, pp. 121709-121709
Closed Access | Times Cited: 12
Combined Cellular Thermometry Reveals That Salmonella typhimurium Warms Macrophages by Inducing a Pyroptosis-like Phenotype
Leyang Wu, Feng Chen, Xiaoyao Chang, et al.
Journal of the American Chemical Society (2022) Vol. 144, Iss. 42, pp. 19396-19409
Closed Access | Times Cited: 17
Leyang Wu, Feng Chen, Xiaoyao Chang, et al.
Journal of the American Chemical Society (2022) Vol. 144, Iss. 42, pp. 19396-19409
Closed Access | Times Cited: 17
Physiochemically and Genetically Engineered Bacteria: Instructive Design Principles and Diverse Applications
Xia Lin, Rong Jiao, Haowen Cui, et al.
Advanced Science (2024) Vol. 11, Iss. 30
Open Access | Times Cited: 2
Xia Lin, Rong Jiao, Haowen Cui, et al.
Advanced Science (2024) Vol. 11, Iss. 30
Open Access | Times Cited: 2
Programmable Bacteria with Dynamic Virulence Modulation System for Precision Antitumor Immunity
Leyang Wu, Lin Li, Liyuan Qiao, et al.
Advanced Science (2024)
Open Access | Times Cited: 2
Leyang Wu, Lin Li, Liyuan Qiao, et al.
Advanced Science (2024)
Open Access | Times Cited: 2
Nanozymes in cancer immunotherapy: metabolic disruption and therapeutic synergy
X Xu, Yaowen Zhang, Chijun Meng, et al.
Journal of Materials Chemistry B (2024) Vol. 12, Iss. 37, pp. 9111-9143
Open Access | Times Cited: 2
X Xu, Yaowen Zhang, Chijun Meng, et al.
Journal of Materials Chemistry B (2024) Vol. 12, Iss. 37, pp. 9111-9143
Open Access | Times Cited: 2
Safety aspects of microorganisms deliberately released into the environment
Alexandra Lensch, Hanna E. Lindfors, Elke Duwenig, et al.
EFB Bioeconomy Journal (2023) Vol. 4, pp. 100061-100061
Open Access | Times Cited: 7
Alexandra Lensch, Hanna E. Lindfors, Elke Duwenig, et al.
EFB Bioeconomy Journal (2023) Vol. 4, pp. 100061-100061
Open Access | Times Cited: 7
Bacteria-driven bio-therapy: From fundamental studies to clinical trials
Yuxuan Yu, Sicen Lin, Zhichao Chen, et al.
Nano Today (2022) Vol. 48, pp. 101731-101731
Closed Access | Times Cited: 12
Yuxuan Yu, Sicen Lin, Zhichao Chen, et al.
Nano Today (2022) Vol. 48, pp. 101731-101731
Closed Access | Times Cited: 12
Elucidation of the Tissue Distribution and Host Immunostimulatory Activity of Exogenously Administered Probiotic-Derived Extracellular Vesicles for Immunoadjuvant
Masaki Morishita, Masakatsu Kida, Tomomi Motomura, et al.
Molecular Pharmaceutics (2023) Vol. 20, Iss. 12, pp. 6104-6113
Closed Access | Times Cited: 5
Masaki Morishita, Masakatsu Kida, Tomomi Motomura, et al.
Molecular Pharmaceutics (2023) Vol. 20, Iss. 12, pp. 6104-6113
Closed Access | Times Cited: 5
Drug-Loaded Biomimetic Carriers for Non-Hodgkin’s Lymphoma Therapy: Advances and Perspective
Xiaoqi Li, Yu Zhang, Chao Wang, et al.
ACS Biomaterials Science & Engineering (2024) Vol. 10, Iss. 2, pp. 723-742
Closed Access | Times Cited: 1
Xiaoqi Li, Yu Zhang, Chao Wang, et al.
ACS Biomaterials Science & Engineering (2024) Vol. 10, Iss. 2, pp. 723-742
Closed Access | Times Cited: 1
Oncolytic bacteria VNP20009 expressing IFNβ inhibits melanoma progression by remodeling the tumor microenvironment
Lina Liu, Qiang Li, Chen Chen, et al.
iScience (2024) Vol. 27, Iss. 4, pp. 109372-109372
Open Access | Times Cited: 1
Lina Liu, Qiang Li, Chen Chen, et al.
iScience (2024) Vol. 27, Iss. 4, pp. 109372-109372
Open Access | Times Cited: 1
Bacteria-based cancer therapy: Looking forward
My-Van Tieu, Duc-Trung Pham, Sungbo Cho
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2024) Vol. 1879, Iss. 4, pp. 189112-189112
Closed Access | Times Cited: 1
My-Van Tieu, Duc-Trung Pham, Sungbo Cho
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2024) Vol. 1879, Iss. 4, pp. 189112-189112
Closed Access | Times Cited: 1
Harnessing and Mimicking Bacterial Features to Combat Cancer: From Living Entities to Artificial Mimicking Systems
Peng Gao, Zhenyu Duan, Gang Xu, et al.
Advanced Materials (2024) Vol. 36, Iss. 35
Closed Access | Times Cited: 1
Peng Gao, Zhenyu Duan, Gang Xu, et al.
Advanced Materials (2024) Vol. 36, Iss. 35
Closed Access | Times Cited: 1